IMPAACT 2010, phase III study of the virologic efficacy and safety of dolutegravir-containing versus efavirenz-containing antiretroviral therapy regimens in HIV-1-infected pregnant women and their infants ?VESTED? Virologic Efficacy and Safety of ART Combinations with TAF/TDF, EFV and DTG

Acces sibility Controls

Implementing Organization

Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Maharashtra

Principal Investigator

Prof Pradip Sambarey

Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals (BJMC), Maharashtra

Abstract

Patents

Achievements

Outcome / Output

Publications

Related Research

View All

Funding Organization

National Institutes of Health (NIH), USA

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

HIV/AIDS/STD

Start Year

2017

End Year

2020

Sanction Amount

₹ 92.19 L

Status

Completed

Contact

drsambarey@yahoo.co.in

Output

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

No. of Patents

Filed : 00

Grant : 00

Acces sibility Controls

Research Projects